All AbMole products are for research use only, cannot be used for human consumption.
Enfuvirtide (T20; DP178) is an anti-HIV-1 fusion inhibitor peptide.
| Molecular Weight | 4491.88 |
| CAS Number | 159519-65-0 |
| Solubility (25°C) | DMSO 20 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Lohini Sundharkrishnan, et al. Cutis. Enfuvirtide-Induced Cutaneous Amyloidosis
[2] Jacob P Lalezari, et al. Drugs Today (Barc). Enfuvirtide
[3] Toni M Dando, et al. Drugs. Enfuvirtide
[4] Jason LaBonte, et al. Nat Rev Drug Discov. Enfuvirtide
[5] Ray Y Chen, et al. Expert Opin Investig Drugs. Enfuvirtide
| Related Anti-infection Products |
|---|
| BTZ043 Racemate
BTZ043 Racemate (BTZ038, BTZ044) is a decaprenylphosphoryl-b-D-ribose 2-epimerase inhibitor. |
| Cidofovir
Cidofovir (Vistide) is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis. |
| Entecavir Monohydrate
Entecavir Hydrate is a class of antiviral compounds. |
| Oseltamivir
Oseltamivir is a potent and selective inhibitor of influenza virus neuraminidase enzyme. |
| Zanamivir
Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A virus and influenza B virus. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
